Clozapine's REMS Program Officially Over

Clozapine's REMS Program Officially Over

(MedPage Today) -- The FDA has officially eliminated clozapine's risk evaluation and mitigation strategy (REMS) program, with all REMS operations stopped as of June 13. The announcement comes several months after a joint FDA advisory committee...

FDA Officially Eliminates Clozapine REMS

The FDA's removal of clozapine REMS enhances access to treatment, while new educational initiatives empower clinicians to improve patient care.